HealthEquity, Inc. (NASDAQ:HQY) Stock Has Consensus Target Price of $112.20

Shares of HealthEquity, Inc. (NASDAQ:HQY) have been assigned a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, ten have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $112.20.

Several analysts recently issued reports on HQY shares. Barclays upped their price objective on shares of HealthEquity from $110.00 to $115.00 and gave the company an “overweight” rating in a research note on Friday, September 18th. BTIG Research reiterated a “buy” rating and issued a $115.00 price objective on shares of HealthEquity in a report on Friday, August 28th. Weiss Ratings lowered shares of HealthEquity from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 2nd. Citigroup restated a “market outperform” rating on shares of HealthEquity in a report on Friday, August 28th. Finally, Wall Street Zen upgraded HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday, October 10th.

Insider Transactions at HealthEquity

In related news, Director Adrian Dillon sold 7,632 shares of the business’s stock in a transaction dated Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total value of $798,383.52. Following the sale, the director directly owned 62,395 shares in the company, valued at approximately $6,527,140.95. The trade was a 10.90% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.60% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

Institutional investors have recently made changes to their positions in the stock. BlackRock Inc. acquired a new stake in shares of HealthEquity in the second quarter valued at $1,018,621,000. Wasatch Advisors LP raised its holdings in shares of HealthEquity by 10.5% in the 2nd quarter. Wasatch Advisors LP now owns 7,960,735 shares of the company’s stock valued at $719,014,000 after buying an additional 757,801 shares during the period. William Blair Investment Management LLC acquired a new position in HealthEquity during the 2nd quarter worth about $160,158,000. Dimensional Fund Advisors LP lifted its stake in HealthEquity by 2.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,627,039 shares of the company’s stock worth $135,957,000 after acquiring an additional 45,287 shares in the last quarter. Finally, Bank of America Corp DE purchased a new position in HealthEquity during the 2nd quarter valued at about $103,573,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Price Performance

Shares of HealthEquity stock traded down $0.48 during mid-day trading on Friday, reaching $92.03. 550,683 shares of the stock traded hands, compared to its average volume of 911,772. The business has a 50-day moving average of $96.08 and a 200 day moving average of $91.40. HealthEquity has a fifty-two week low of $72.76 and a fifty-two week high of $107.62. The stock has a market capitalization of $7.61 billion, a PE ratio of 33.22, a PEG ratio of 1.46 and a beta of 0.24. The company has a quick ratio of 2.99, a current ratio of 2.99 and a debt-to-equity ratio of 0.47.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Thursday, August 27th. The company reported $1.24 EPS for the quarter, beating analysts’ consensus estimates of $1.19 by $0.05. The business had revenue of $350.73 million during the quarter, compared to analysts’ expectations of $349.22 million. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. HealthEquity’s revenue for the quarter was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. On average, analysts predict that HealthEquity will post 3.93 EPS for the current year.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) provides technology-enabled services for consumer-directed health and benefits accounts. The company administers health savings accounts (HSAs) and offers related products such as flexible spending accounts, health reimbursement arrangements, commuter benefits and other employee benefit programs.

Its platform is designed to help employers, benefits advisors, health plans and individuals manage benefits, make healthcare payments, access account information and invest eligible HSA funds.